Philippe Haas
Overview
Explore the profile of Philippe Haas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaun F, Boesing M, Luethi-Corridori G, Abig K, Bloch N, Giezendanner S, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37238948
Vitamin D and its role in the coronavirus-19 disease (COVID-19) pandemic has been controversially discussed, with inconclusive evidence about vitamin D3 (cholecalciferol) supplementation in COVID-19 patients. Vitamin D metabolites play...
2.
Boesing M, Abig K, Brandle M, Brutsche M, Burri E, Frye B, et al.
Trials
. 2022 Sep;
23(1):790.
PMID: 36127739
Background: Despite the fast establishment of new therapeutic agents in the management of COVID-19 and large-scale vaccination campaigns since the beginning of the SARS-CoV-2 pandemic in early 2020, severe disease...
3.
Jaun F, Boesing M, Luthi-Corridori G, Abig K, Makhdoomi A, Bloch N, et al.
Trials
. 2022 Feb;
23(1):114.
PMID: 35120577
Background: The coronavirus disease 19 (COVID-19) pandemic has caused millions of deaths, and new treatments are urgently needed. Factors associated with a worse COVID-19 prognosis include old age (> 65 ...
4.
Zusli S, Bierreth F, Boesing M, Haas P, Abig K, Maier S, et al.
Contemp Clin Trials Commun
. 2021 Sep;
23:100825.
PMID: 34485753
Despite important advances in diagnosis and medical therapy of heart failure (HF), disease monitoring and therapy guidance remains to be based on clinical signs and symptoms. NT-proBNP was repeatedly demonstrated...
5.
Kheav V, Busson M, Scieux C, Peffault de Latour R, Maki G, Haas P, et al.
Haematologica
. 2014 Aug;
99(12):1860-7.
PMID: 25085354
Natural killer cells are the first lymphocyte subset to reconstitute, and play a major role in early immunity after allogeneic hematopoietic stem cell transplantation. Cells expressing the activating receptor NKG2C...
6.
Haas P, Loiseau P, Tamouza R, Cayuela J, Moins-Teisserenc H, Busson M, et al.
Blood
. 2010 Nov;
117(3):1021-9.
PMID: 21045194
The rules governing natural killer (NK)-cell education in the allogeneic environment created by unrelated hematopoietic stem-cell transplantation (HSCT) are still largely elusive, especially in an unrelated donor setting. NK-cell inhibitory...
7.
Haas P, Then P, Wild A, Grange W, Zorman S, Hegner M, et al.
Anal Chem
. 2010 Jun;
82(14):6299-302.
PMID: 20568715
The applicability of single-molecule fluorescence assays in liquids is limited by diffusion to concentrations in the low picomolar range. Here, we demonstrate quantitative single-molecule detection at attomolar concentrations within 1...
8.
Boukouaci W, Busson M, Peffault de Latour R, Rocha V, Suberbielle C, Bengoufa D, et al.
Blood
. 2009 Sep;
114(25):5216-24.
PMID: 19786616
The MHC class I-related chain A (MICA) molecules exist as membrane-bound and soluble isoforms and are encoded by a polymorphic gene. Their genetic and phenotype characteristics have been studied in...
9.
Peraldi M, Berrou J, Dulphy N, Seidowsky A, Haas P, Boissel N, et al.
J Immunol
. 2009 Jan;
182(3):1696-705.
PMID: 19155520
To characterize the immune defect of patients with end-stage renal disease (ESRD), we performed NK cell subset analysis in 66 patients with ESRD treated by hemodialysis (n = 59) or...
10.
Dulphy N, Haas P, Busson M, Belhadj S, Peffault de Latour R, Robin M, et al.
J Immunol
. 2008 Jul;
181(3):2227-37.
PMID: 18641363
The expansion of the cytokine-producing CD56(bright) NK cell subset is a main feature of lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation (HSCT). We investigated phenotypes and functions of CD56(bright)...